Expression of TIP60 (tat‐interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment‐specific outcome of localised invasive bladder cancerJens R. Laurberg, Lars Dyrskjøt, Mads Agerbæk et al.|British Journal of Urology|2012Cited by 101
Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation StudyLars Dyrskjøt, Torben F. Ørntoft, Thomas Reinert et al.|European Urology|2017Cited by 100
Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk GroupsKim E.M. van Kessel, Ellen C. Zwarthoff, Kirstin A. van der Keur et al.|Clinical Cancer Research|2018Cited by 92